Ginkgo Bioworks Holdings GAAP EPS of -$1.08 beats by $2.24, revenue of $89.05M beats by $44.06M
seekingalpha
2024-11-13
Ginkgo Bioworks Holdings press release (NYSE:DNA): Q3 GAAP EPS of -$1.08 beats by $2.24.
Revenue of $89.05M (+60.7% Y/Y) beats by $44.06M.
Q4 Outlook: Ginkgo previously issued 2024 guidance for Total revenue of $170-190 million; Cell Engineering services revenue of $120-140 million; and Biosecurity